Amyris (AMRS:NASDAQ) Investor Relations Material

Overview

Amyris, Inc.: A Biotech Company with a Global Footprint Emeryville, California-based Amyris, Inc. is making waves as a biotechnology company operating across Europe, North America, Asia, South America, and beyond. The company is focused on creating, producing, and selling consumer products and ingredients, including clean beauty, personal care, and health and wellness consumer products. Its products are marketed under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names. Amyris is also catering to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company has been in operation since 2003, but was formerly known as Amyris Biotechnologies, Inc. It changed its name to Amyris, Inc. in June 2010. Amyris, Inc. is at the forefront of the fight against COVID-19, with a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company's global presence and diverse portfolio make it an exciting biotech company to watch in the coming years.

Frequently Asked Questions

What is Amyris's ticker?

Amyris's ticker is AMRS

What exchange is Amyris traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Amyris's headquarters?

They are based in Emeryville, California

How many employees does Amyris have?

There are 1001-5000 employees working at Amyris

What is Amyris's website?

It is amyris.com/?_ga=2.224072667.1993559408.1623842737-1680177511.1623842737

What type of sector is Amyris?

Amyris is in the Basic Materials sector

What type of industry is Amyris?

Amyris is in the Specialty Chemicals industry

Who are Amyris's peers and competitors?

The following five companies are Amyris's industry peers:

- Chase Corporation

- Victrex

- Axalta Coating Systems

- Iofina Plc

- Oil-Dri of America